A new study has found that an RNA-binding protein called TDP-43 could be a promising new biomarker for diagnosing amyotropic lateral sclerosis.
Baseline Amyloid PET Centiloid Levels Show No Impact on Lecanemab ARIA-E Rates
Episode 106: Potential Role of Stathmin-2 in Amyotrophic Lateral Sclerosis
Switching to Subcutaneous Zilucoplan Raises No Safety Concerns in Myasthenia Gravis
Episode 105: Recapping Conversations in Neurology From 2023
This Week on NeurologyLive® — April 15, 2024
NeurologyLive® Brain Games: April 14, 2024